Retinal diseases affect the layer of tissue at the back of the eye called the retina, which is essential to vision. Some retinal diseases specifically affect the macula – the part of the retina responsible to central vision. Although many retinal conditions share similar symptoms, it is important that your ophthalmologist has the extensive experience and training to differentiate between these diseases and administer the appropriate treatments.
AMD is a condition in which the central portion of the retina (the macula) deteriorates, causing central vision loss. It comes in “dry” and “wet” forms, with dry AMD occurring much more commonly. In the dry form, cellular debris, called drusen, may accumulate behind the retina and may cause it to become detached or the retina may simply atrophy. Wet AMD, which is much rarer and more severe, occurs when abnormal blood vessels form as a complication of the dry disease and cause rapid vision loss.
While there is no cure for dry AMD, nutritional supplements rich in certain antioxidants have been shown to slow the progression of this condition. Until recently, wet AMD was not treatable, and resulted in rapid vision loss. To aid in the rapid diagnosis we employ Optical Coherence Tomography including the advanced Heidelberg Spectralis. Optical Coherence Tomography (OCT) is a non-invasive technology used for imaging the retina. OCT alllows doctors to see cross-sectional images of the retina and greatly aids in the early detection and treatment of eye conditions such as macular holes, pre-retinal membranes, macular swelling and even optic nerve damage. At our offices in New Jersey, patients from in and around Princeton, and Monroe Township with wet macular degeneration can now be treated with Lucentis®, an innovative drug therapy that can abate the abnormal blood vessels and improve vision. Lucentis treatments involve a monthly or bi-monthly injection into the vitreous humor of the eye.
People prefer Outlook Eyecare for many reasons including our:
Prolonged diabetes can cause swelling of the blood vessels in the back of the eye, which may leak fluid and cause blurry vision. This is called nonproliferative diabetic retinopathy, and is the more common and early stage of the disease. Your ophthalmologist will monitor this condition closely, and work to slow its progress by making sure that your diabetes is well controlled.
As the disease advances, it causes abnormal blood vessels to grow around the retina, which often break and bleed into the vitreous. This causes clouded or blocked vision, and may result in retinal detachment. Treatments for this condition include laser therapy and Lucentis injections to slow the growth of abnormal blood vessels.
Outlook Eyecare is at the forefront of treatment advances for conditions such as wet macular degeneration and diabetic retinopathy using Lucentis. We employ Lucentis in an innovative drug therapy which can abate abnormal blood vessels and improve vision. Lucentis treatments involve a monthly or bi-monthly injection into the vitreous humor of the eye. Through this treatment, patients can preserve vision without surgery.
There are numerous other retinal diseases and conditions that we treat at Outlook Eyecare. We carefully evaluate each of our patients for signs of retinal disease, to accurately and promptly diagnose and treat their condition and preserve vision.
2019 Outlook Eyecare © All rights reserved.